Ignite Creation Date:
2024-05-06 @ 12:11 PM
Last Modification Date:
2024-10-26 @ 12:55 PM
Study NCT ID:
NCT03691766
Status:
COMPLETED
Last Update Posted:
2021-02-26
First Post:
2018-09-28
Brief Title:
Photobiomodulation Therapy in Persons With Multiple Sclerosis
Sponsor:
Marquette University
Organization:
Marquette University
Study Overview
Official Title:
Effect of Photobiomodulation Therapy on Muscle Function and Inflammation in Persons With Multiple Sclerosis
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will test whether photobiomodulation therapy improves muscle endurance and decreases inflammation in persons with relapsing-remitting multiple sclerosis We will also investigate mechanisms for any improvements
Detailed Description:
Persons with multiple sclerosis MS MS commonly experience muscle weakness and fatigue which may contribute to the commonly reported symptomatic fatigue Photobiomodulation therapy PBMT induced with light in the visible red to near infrared VISNIR region of the spectrum 600-1000 nm can stimulate cytochrome c oxidase and improve mitochondrial function PBMT is an emerging therapeutic modality for soft tissue injury chronic inflammation neurodegeneration and retinal diseases PBMT has also been used to enhance muscle endurance strength and recovery in healthy adults We propose that in persons with MS PBMT will 1 enhance regional muscle endurance after acute treatment and 2 enhance functional endurance after extended treatment We will also test to determine if improvements are due to central or peripheral neuromuscular or cardiovascular mechanisms Final we will explore if regional PBMT can result in systemic anti-inflammatory effects
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None